INTELLIA THERAPEUTICS, INC. Environmental Analytics
Environmental and financial analysis dashboard for INTELLIA THERAPEUTICS, INC.. Industry: PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Company Overview for INTELLIA THERAPEUTICS, INC.
Highlights
Showing data for FY2022
Operational Environmental Cost
$0.58m
Operational Environmental Cost Intensity
1.11%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$0.34m
Decoupling Rate (2020-2022)
-63%
Adjusted EBITDA
$-451m
Adjusted EBITDA Margin
-866%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| -31.23% | 56.83% | -38.68% | ||
| 0.15% | 0.18% | 0.17% | 0.15% | |
| 23.87% | 151.02% | -36.34% | ||
| 0.27% | 0.59% | 0.93% | 0.85% | |
| $0m | $0m | $1m | $0m | |
| 4.58% | 129.33% | -36.71% | ||
| 0.42% | 0.76% | 1.11% | 1.01% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
-866%
Adjusted EBIT Margin
-880%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$58m | $33m | $52m | $36m | |
| -43.01% | 57.70% | -30.39% | ||
$188m | $294m | $503m | $543m | |
| 324.63% | 889.52% | 964.51% | 1495.77% | |
$-130m | $-261m | $-451m | $-506m | |
| -224.63% | -789.52% | -864.51% | -1395.77% | |
$-137m | $-268m | $-458m | $-515m | |
| -235.51% | -810.37% | -879.04% | -1420.51% | |
| ENVIRONMENTAL COST DATA | ||||
$0m | $0m | $1m | $0m | |
| 0.42% | 0.76% | 1.11% | 1.01% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$-131m | $-261m | $-451m | $-507m | |
| -225.05% | -790.28% | -865.62% | -1396.78% | |
$-137m | $-268m | $-459m | $-516m | |
| -235.93% | -811.13% | -880.15% | -1421.52% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Scope 1 (% of Sales)
0.17%
Scope 2 (% of Sales)
0.93%
Operational Environmental Cost Intensity
1.11%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
INTELLIA THERAPEUTICS, INC. | US | $1m | 1.11% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022